Carlos Lopez, commercial director of Spring Genetics in Miami, Fla., explains the company's history, its focus on growth and disease resistance, and the importance of biosecurity. He details the facility's operations, including the use of UV-treated water, restricted access, and health surveillance. He also offers his thoughts on tilapia aquaculture's potential to expand in the U.S. market, and the potential for future technological advancements in production.